These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20456623)

  • 1. Androgen blockade for the treatment of high-flow priapism.
    Mwamukonda KB; Chi T; Shindel AW; Lue TF
    J Sex Med; 2010 Jul; 7(7):2532-7. PubMed ID: 20456623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes.
    Hoeh MP; Levine LA
    J Sex Med; 2014 Jan; 11(1):197-204. PubMed ID: 24433561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of high-flow priapism with superselective transcatheter embolization in 27 patients: a multicenter study.
    Kim KR; Shin JH; Song HY; Ko GY; Yoon HK; Sung KB; Ahn TY; Kim CW; Kim YH; Ko HK; Kwak BK; Shim HJ; Chung HH; Shin SW; Bae JI
    J Vasc Interv Radiol; 2007 Oct; 18(10):1222-6. PubMed ID: 17911511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiandrogens in the treatment of priapism.
    Dahm P; Rao DS; Donatucci CF
    Urology; 2002 Jan; 59(1):138. PubMed ID: 11796309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity.
    Petit JH; Gluck C; Kiger WS; Henry DL; Karasiewicz C; Talcott J; Berg S; Holupka E; Kaplan I
    Urol Oncol; 2008; 26(4):372-7. PubMed ID: 18367113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy.
    Pirl WF; Greer JA; Goode M; Smith MR
    Psychooncology; 2008 Feb; 17(2):148-53. PubMed ID: 17443645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
    Kijima T; Fujii Y; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Koga F; Masuda H; Kawakami S; Kihara K
    BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
    BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
    Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Kishikawa H; Ichikawa Y
    Int J Urol; 2007 Mar; 14(3):264-7. PubMed ID: 17430272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal.
    Motofei IG; Rowland DL; Popa F; Kreienkamp D; Paunica S
    BJU Int; 2011 Jul; 108(1):110-5. PubMed ID: 20955264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
    Gardiner RA; Nicol DL; Green HJ; Yaxley J; Watson R; Mactaggart P; Headley BC; Swanson C; Pakenham KI
    J Urol; 2004 Aug; 172(2):774; author reply 774-5. PubMed ID: 15247782
    [No Abstract]   [Full Text] [Related]  

  • 13. Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: a retrospective chart review.
    Curtis KK; Adam TJ; Chen SC; Pruthi RK; Gornet MK
    Aging Male; 2008 Dec; 11(4):157-61. PubMed ID: 18937151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of erection function in patients with prostatic carcinoma treated with Casodex].
    Migliari R; Muscas G; Melis M; Garau M; Sorgia M; Scarpa RM; Usai E
    Arch Ital Urol Nefrol Androl; 1991 Mar; 63(1):155-61. PubMed ID: 1830408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
    Scher HI; Liebertz C; Kelly WK; Mazumdar M; Brett C; Schwartz L; Kolvenbag G; Shapiro L; Schwartz M
    J Clin Oncol; 1997 Aug; 15(8):2928-38. PubMed ID: 9256137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy.
    Hanisch LJ; Gehrman PR
    Aging Male; 2011 Dec; 14(4):243-8. PubMed ID: 21627561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Total androgen blockade].
    Namiki M; Mizokami A
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():193-8. PubMed ID: 12599570
    [No Abstract]   [Full Text] [Related]  

  • 18. Posttraumatic nonischemic priapism treated with autologous blood clot embolization.
    Numan F; Cantasdemir M; Ozbayrak M; Sanli O; Kadioglu A; Hasanefendioglu A; Bas A
    J Sex Med; 2008 Jan; 5(1):173-9. PubMed ID: 18173765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-flow priapism due to bilateral cavernous artery fistulas treated by unilateral embolization: A case report.
    Li G; Liu Y; Wang HY; Du FZ; Zuo ZW
    World J Clin Cases; 2023 Jan; 11(1):225-232. PubMed ID: 36687183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer.
    Chu FM; Sartor O; Gomella L; Rudo T; Somerville MC; Hereghty B; Manyak MJ
    Eur J Cancer; 2015 Aug; 51(12):1555-69. PubMed ID: 26048455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.